期刊文献+

食管癌化疗患者生存质量测定量表中文版的研制与考评 被引量:15

Development and evaluation on measurement instrument of quality of life for patients with esophageal cancer:Chinese version of EORTC QLQ-OES18
下载PDF
导出
摘要 目的:应用欧洲癌症研究与治疗组织(EORTC)开发的问卷表QLQ-OES18为蓝本来研制其中文版,并对其进行考评。方法:通过量表的翻译、回译和文化调适制定出中文版的QLQ-OES18,并通过考查133例食管癌患者的生存质量对量表进行评价。对EORTCQLQ-OES18中文版量表主要进行信度、效度和反应度三方面的考评,采用克朗巴赫系数考察内部一致性;计算各个领域及方面间相关系数来分析量表的内容效度;使用配对t检验进行第1、2次测定及第1、3次测定得分均数的比较,考察量表的区分效度。结果:EORTCQLQ-OES18显示出较好的可靠性和良好的鉴别能力,能显示出化疗带来的生存质量改变。各领域内部一致性的信度都在0.61以上;各条目与其领域的相关系数值在0.6以上。结论:QLQ-OES18显示出较好的心理测定学和临床有效性,可推荐其与核心量表QLQ-C30联用,用来评估化疗后食管癌患者的生存质量。 Objective: To evaluate the psychometric properties and clinical validity of the Chinese version of EORTC QLQ - OES18 in a sample of esophageal cancer patients in China. Methods: Chinese version of EORTC QLQ -OES18 was developed by translation and back -translation and culture- adaptation, and evaluated by QOL data measured in 133 patients of esophageal cancer. Results: Questionnaires were well accepted, compliance rate were high. The internal consistency for each domain was higher than 0.61 ; each correlation coefficient between single item and its domain was beyond 0.6. Selective scales demonstrated treatment - induced changes over time. Conclusion: The Chinese version of EORTC QLQ - OES18 demonstrates good psychometric and clinical validity. It is recommended for use with the core questionnaire, the QLQ -c30, to assess QOL in patients with esophageal cancer.
出处 《现代肿瘤医学》 CAS 2007年第12期1792-1794,共3页 Journal of Modern Oncology
关键词 生存质量 食管肿瘤 化学疗法 量表评价 quality of life esophageal cancer chemotherapy questionnaire evaluation
  • 相关文献

参考文献7

  • 1全国肿瘤防治研究办公室.中国恶性肿瘤危险因素研究[M].北京:中国协和医科大学出版社,2003.244-248.
  • 2Blazeby JM, Alderson D, Winstone K, et al. Development of an EORTC Questionnaire Module to be used in Quality of Life assessment for patients with oesophageal cancer [ J ]. Eur J Cancer, 1996,32( 11 ) :1912 - 1917.
  • 3Blazeby JM, Conroy T, Hammedid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ -OES18 ,to assess quality of life in patients with oesophageal cancer[ J]. Eur J Cancer,2003,39(10) : 1384 - 1394.
  • 4Fayers PM, Asronson NK, Bjordal K, et al. On behalf of the EORTC Quality of Life Study Group. The EORTC QLQ - C30 scoring manual. [ M]. 3^rd ed Brussels: EORTC,2001.
  • 5Ross P,Nicolson M,Cunningham D,et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous - infusion fluorouracil (PVI 5 - FU) with epirubicin, cisplatin, and PVI 5 - FU in advanced esophagogastric cancer[J]. J Clin Oncol,2002, 20(8) :1996 -2004.
  • 6Stoller JL, Samer KJ, Toppin DI, et al. Carcinoma of the esophagus. A new proposal for the evaluation of treatment [ J ]. Can J Surg, 1977,20 ( 5 ) :454 - 459.
  • 7Blazeby JM, Nicklin J, Brookes ST, et al. Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer [ J ]. Br J Cancer,2003,89 ( 3 ) :497 - 501.

共引文献41

同被引文献167

引证文献15

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部